Intraocular melanoma is a rare form of cancer that develops in the eye's melanocytes, the cells responsible for producing melanin. Although uncommon, it is the most common primary intraocular malignancy in adults. Research into intraocular melanoma focuses on understanding its genetic basis, risk factors, and treatment options. Advances in molecular biology have identified genetic mutations associated with the disease, aiding in personalized treatment strategies. Current research efforts also explore novel therapies, including targeted drugs and immunotherapy, to improve outcomes for patients. Early detection through regular eye exams remains crucial for effective management, highlighting the importance of ongoing research in combating this challenging disease.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China